Youdim Pharmaceuticals
Sector: Healthcare & Life Sciences
About Youdim Pharmaceuticals
Youdim – Pharma incubator Toggle navigation Home About Team Portfolio Entrepreneurs News & Publications Contact Legacy & Experience Leveraging the capabilities and proven scientific genius of Professor Youdim, and the team’s business knowhow and track record for success in promoting science-based startups they develop successful companies in the pharma and medical device fields. The science of Pha
Products
Exegiline
Youdim Pharmaceuticals is developing a novel oral drug, MT-031, for the treatment of the symptoms related to Alzheimer’s Disease. MT-031 structure combines Rivastigmine (Exelon) and Rasagiline (Azilect) moieties and it has the beneficial properties of both and more. The molecule and its indications are protected by a recently granted US and EP patents.